HPV genotype prevalence in cytologically abnormal cervical samples from women living in south Italy

Virus Research

Volumn 133, Issue 2, 2008, Pages 195-200

  Capra, Giuseppina ^a   Giovannelli, Lucia ^a   Bellavia, Carmelina ^a   Migliore, Maria Colomba ^a   Caleca, Maria Pia ^a   Perino, Antonio ^a   Ammatuna, Pietro ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cervical; Distribution; Genotypes; Samples

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; VERRUCA VULGARIS; WART VIRUS;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; ITALY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 41049087581     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.12.020     Document Type: Article

References (38)

1. Albrecht V., Chevallier A., Bongain A., Lefebvre J.C., and Giordanengo V. Immunohistochemical and molecular study of severe cervical dysplasia associated with HPV-83. Gynecol. Oncol. 105 1 (2007) 252-255
2. Arbyn M., Sasieni P., Meijer C.J., Clavel C., Koliopoulos G., and Dillner J. Chapter 9: clinical applications of HPV testing: a summary of meta-analyses. Vaccine 24 Suppl. 3 (2006) S78-S89
3. Baseman J.G., and Koutsky L.A. The epidemiology of human papillomavirus infections. J. Clin. Virol. 32 Suppl. 1 (2005) S16-S24
4. Beerens E., Van Renterghem L., Praet M., Sturtewagen Y., Weyers S., Temmerman M., Depypere H., Claeys P., and Cuvelier C.A. Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: prevalence and distribution of HPV genotypes. Cytopathology 16 4 (2005) 199-205
5. Bosch F.X., and Munoz N. The viral etiology of cervical cancer. Virus Res. 89 2 (2002) 183-190
6. Brown D.R., Legge D., and Qadadri B. Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted diseases clinic. Sex. Transm. Dis. 29 12 (2002) 763-768
7. Centurioni M.G., Puppo A., Merlo D.F., Pasciucco G., Cusimano E.R., Sirito R., and Gustavino C.A. Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population. BMC Infect. Dis. 5 (2005) 77
8. Chow V.T., and Leong P.W. Complete nucleotide sequence, genomic organization and phylogenetic analysis of a novel genital human papillomavirus type, HLT7474-S. J. Gen. Virol. 80 Pt 11 (1999) 2923-2929
9. Clifford G.M., Smith J.S., Plummer M., Munoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88 1 (2003) 63-73
10. Clifford G.M., Gallus S., Herrero R., Munoz N., Snijders P.J., Vaccarella S., Anh P.T., Ferreccio C., Hieu N.T., Matos E., Molano M., Rajkumar R., Ronco G., de Sanjose S., Shin H.R., Sukvirach S., Thomas J.O., Tunsakul S., Meijer C.J., and Franceschi S. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 9490 (2005) 991-998
11. De Francesco M.A., Gargiulo F., Schreiber C., Ciravolo G., Salinaro F., and Manca N. Detection and genotyping of human papillomavirus in cervical samples from Italian patients. J. Med. Virol. 75 4 (2005) 588-592
12. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., and zur Hausen H. Classification of papillomaviruses. Virology 324 1 (2004) 17-27
13. Depuydt C.E., Boulet G.A., Horvath C.A., Benoy I.H., Vereecken A.J., and Bogers J.J. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J. Cell Mol. Med. 11 4 (2007) 881-891
14. Evans M.F., Adamson C.S., Papillo J.L., St John T.L., Leiman G., and Cooper K. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 106 5 (2006) 1054-1064
15. Franco E.L., Villa L.L., Sobrinho J.P., Prado J.M., Rousseau M.C., Desy M., and Rohan T.E. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J. Infect. Dis. 180 5 (1999) 1415-1423
16. Gargiulo F., De Francesco M.A., Schreiber C., Ciravolo G., Salinaro F., Valloncini B., and Manca N. Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Virus Res. 125 2 (2007) 176-182
17. Giovannelli L., Lama A., Capra G., Giordano V., Arico P., and Ammatuna P. Detection of human papillomavirus DNA in cervical samples: analysis of the new PGMY-PCR compared to the hybrid capture II and MY-PCR assays and a two-step nested PCR assay. J. Clin. Microbiol. 42 8 (2004) 3861-3864
18. Hildesheim A., and Wang S.S. Host and viral genetics and risk of cervical cancer: a review. Virus Res. 89 2 (2002) 229-240
19. Ho G.Y., Palan P.R., Basu J., Romney S.L., Kadish A.S., Mikhail M., Wassertheil-Smoller S., Runowicz C., and Burk R.D. Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int. J. Cancer 78 5 (1998) 594-599
20. Husnjak K., Grce M., Magdic L., and Pavelic K. Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J. Virol. Methods 88 2 (2000) 125-134
21. Iftner T., and Villa L.L. Chapter 12: human papillomavirus technologies. J. Natl. Cancer Inst. Monogr. 31 (2003) 80-88
22. Kleter B., van Doorn L.J., Schrauwen L., Molijn A., Sastrowijoto S., ter Schegget J., Lindeman J., ter Harmsel B., Burger M., and Quint W. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37 8 (1999) 2508-2517
23. Lonky N.M., Felix J.C., Naidu Y.M., and Wolde-Tsadik G. Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation. Obstet. Gynecol. 101 3 (2003) 481-489
24. Melchers W.J., Bakkers J.M., Wang J., de Wilde P.C., Boonstra H., Quint W.G., and Hanselaar A.G. Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am. J. Pathol. 155 5 (1999) 1473-1478
25. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., Snijders P.J., and Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 6 (2003) 518-527
26. Petry K.U., Kupsch E., Luck H.J., and Werner M. Correlation of human papillomavirus DNA detection in biopsies of cervical lesions and the corresponding cervical swabs with the same method of in situ hybridization. Acta Virol. 37 4 (1993) 251-257
27. Prinsen C.F., Fles R., Wijnen-Dubbers C.W., de Valk H.A., Klaassen C.H., Mravunac M., Horrevorts A.M., and Thunnissen F.B. Baseline human papillomavirus status of women with abnormal smears in cervical screening: a 5-year follow-up study in The Netherlands. BJOG 114 8 (2007) 951-957
28. Qu W., Jiang G., Cruz Y., Chang C.J., Ho G.Y., Klein R.S., and Burk R.D. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J. Clin. Microbiol. 35 6 (1997) 1304-1310
29. Rassu M., Bertoloni G., Mengoli C., Peron A., Benedetti P., and Palu G. HPV genotype prevalence in cervical specimens with abnormal cytology: a report from north-east Italy. Scand. J. Infect. Dis. 37 6-7 (2005) 476-481
30. Ronco G., Ghisetti V., Segnan N., Snijders P.J., Gillio-Tos A., Meijer C.J., Merletti F., and Franceschi S. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur. J. Cancer 41 2 (2005) 297-305
31. Strauss S., Jordens J.Z., Desselberger U., and Gray J.J. Single-tube real-time nested polymerase chain reaction for detecting human papillomavirus DNA. Diagn. Mol. Pathol. 9 3 (2000) 151-157
32. Tornesello M.L., Duraturo M.L., Botti G., Greggi S., Piccoli R., De Palo G., Montella M., Buonaguro L., and Buonaguro F.M. Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population. J. Med. Virol. 78 12 (2006) 1663-1672
33. Vaccarella S., Herrero R., Dai M., Snijders P.J., Meijer C.J., Thomas J.O., Hoang Anh P.T., Ferreccio C., Matos E., Posso H., de Sanjose S., Shin H.R., Sukvirach S., Lazcano-Ponce E., Ronco G., Rajkumar R., Qiao Y.L., Munoz N., and Franceschi S. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol. Biomark. Prev. 15 11 (2006) 2148-2153
34. Vaccarella S., Lazcano-Ponce E., Castro-Garduno J.A., Cruz-Valdez A., Diaz V., Schiavon R., Hernandez P., Kornegay J.R., Hernandez-Avila M., and Franceschi S. Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. Int. J. Cancer 119 8 (2006) 1934-1939
35. van Hamont D., van Ham M.A., Bakkers J.M., Massuger L.F., and Melchers W.J. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test. J. Clin. Microbiol. 44 9 (2006) 3122-3129
36. Vernon S.D., Unger E.R., and Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J. Clin. Microbiol. 38 2 (2000) 651-655
37. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R., Wheeler C.M., Koutsky L.A., Malm C., Lehtinen M., Skjeldestad F.E., Olsson S.E., Steinwall M., Brown D.R., Kurman R.J., Ronnett B.M., Stoler M.H., Ferenczy A., Harper D.M., Tamms G.M., Yu J., Lupinacci L., Railkar R., Taddeo F.J., Jansen K.U., Esser M.T., Sings H.L., Saah A.J., and Barr E. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 6 5 (2005) 271-278
38. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2 5 (2002) 342-350